Nifty

:

22409.65

Sensex

:

73886.90

7.25 (0.03%)
33.96 (0.05%)

Login

Nifty
Sensex

:
:

22409.65
73886.90

7.25 (0.03%)
33.96 (0.05%)

Procter & Gamble Health Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

55/99

BSE: 500126 | NSE: PGHL

Watchlist

NSE BSE

4729.20

24-Apr-2024

Open
High
Low
Previous Close

4750.05
4758.15
4715.00
4726.40

Volume
Traded Value (lacs)
52 Week High
52 Week Low

3971
187.97
5642.85
4575.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,862.05
34.69
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,436.49
2.01%
9.76

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
6.82

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
5.71

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
9.08

P:E (Median)

8 Years
5 Years
3 Years

38.11
46.11
37.13

P:BV (Average)

8 Years
5 Years
3 Years

11.06
11.06
11.51

EV:EBITDA (Average)

8 Years
5 Years
3 Years

22.63
27.06
25.92

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 309.97 309.97 0.00% 304.93 297.55 2.48% 301.18 295.89 1.79% 320.92 267.82 19.83%
Expenses 208.32 201.11 3.59% 216.27 206.73 4.61% 255.84 236.85 8.02% 241.26 199.05 21.21%
EBITDA 101.65 108.86 -6.62% 88.66 90.82 -2.38% 45.34 59.04 -23.20% 79.66 68.77 15.84%
EBIDTM 32.79% 35.12% 29.08% 30.52% 15.05% 19.95% 24.82% 25.68%
Other Income 5.18 4.54 14.10% 6.05 3.42 76.90% 5.46 3.10 76.13% 4.97 2.35 111.49%
Interest 0.19 0.23 -17.39% 0.18 0.16 12.50% 0.17 0.02 750.00% 0.21 0.14 50.00%
Depreciation 6.92 8.23 -15.92% 6.48 7.48 -13.37% 6.50 7.47 -12.99% 5.89 6.12 -3.76%
PBT 99.72 104.94 -4.97% 88.05 86.60 1.67% 44.13 54.65 -19.25% 78.53 64.86 21.08%
Tax 27.65 28.14 -1.74% 22.48 22.94 -2.01% 14.31 13.46 6.32% 19.34 13.70 41.17%
PAT 72.07 76.80 -6.16% 65.57 63.66 3.00% 29.82 41.19 -27.60% 59.19 51.16 15.70%
PATM 23.25% 24.78% 21.50% 21.39% 9.90% 13.92% 18.44% 19.10%
EPS 43.42 46.27 -6.16% 39.50 38.35 3.00% 17.96 24.81 -27.61% 35.66 30.82 15.70%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15 Dec 14 Dec 13
Net Sales 1,237.00 1,229.62 1,114.41 1,008.73 1,355.86 1,288.08 698.13 992.56 939.50 867.49 797.78 Net Sales Growth 5.62% 10.34% 10.48% -25.60% 5.26% 84.50% -29.66% 5.65% 8.30% 8.74% Cost Of Goods Sold 371.46 361.84 339.80 312.12 431.44 269.36 236.94 411.54 437.19 405.06 366.82 Gross Profit 865.54 867.78 774.61 696.61 924.42 1,018.72 461.19 581.02 502.31 462.43 430.96 GP Margin 69.97% 70.57% 69.51% 69.06% 68.18% 79.09% 66.06% 58.54% 53.47% 53.31% 54.02% Total Expenditure 921.69 904.94 846.73 762.71 1,041.52 1,077.93 627.50 876.99 856.06 808.58 720.91 Power & Fuel Cost - 12.88 14.70 12.97 19.09 12.23 11.68 14.96 15.14 9.89 7.48 % Of Sales - 1.05% 1.32% 1.29% 1.41% 0.95% 1.67% 1.51% 1.61% 1.14% 0.94% Employee Cost - 206.17 167.56 153.66 182.93 131.27 109.88 154.23 123.17 113.56 100.96 % Of Sales - 16.77% 15.04% 15.23% 13.49% 10.19% 15.74% 15.54% 13.11% 13.09% 12.66% Manufacturing Exp. - 126.07 132.01 125.61 121.02 72.37 69.14 58.36 70.81 73.68 67.71 % Of Sales - 10.25% 11.85% 12.45% 8.93% 5.62% 9.90% 5.88% 7.54% 8.49% 8.49% General & Admin Exp. - 87.16 60.88 51.79 153.86 94.39 82.02 141.55 116.30 130.45 107.45 % Of Sales - 7.09% 5.46% 5.13% 11.35% 7.33% 11.75% 14.26% 12.38% 15.04% 13.47% Selling & Distn. Exp. - 74.49 109.45 87.41 118.96 115.66 90.72 81.36 84.61 70.44 65.08 % Of Sales - 6.06% 9.82% 8.67% 8.77% 8.98% 12.99% 8.20% 9.01% 8.12% 8.16% Miscellaneous Exp. - 36.33 22.33 19.15 14.22 382.65 27.12 14.99 8.84 5.50 65.08 % Of Sales - 2.95% 2.00% 1.90% 1.05% 29.71% 3.88% 1.51% 0.94% 0.63% 0.68% EBITDA 315.31 324.68 267.68 246.02 314.34 210.15 70.63 115.57 83.44 58.91 76.87 EBITDA Margin 25.49% 26.40% 24.02% 24.39% 23.18% 16.31% 10.12% 11.64% 8.88% 6.79% 9.64% Other Income 21.66 18.39 13.19 18.10 69.96 722.34 83.68 24.41 23.31 20.33 21.45 Interest 0.75 0.77 0.42 0.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Depreciation 25.79 28.10 27.08 30.04 29.45 21.12 19.12 24.81 23.42 12.68 10.07 PBT 310.43 314.20 253.37 233.28 354.85 911.37 135.19 115.17 83.33 66.56 88.25 Tax 83.78 84.73 60.85 56.48 100.77 79.21 58.28 36.04 29.77 23.34 32.37 Tax Rate 26.99% 26.97% 24.02% 24.21% 28.40% 8.63% 38.29% 31.29% 35.73% 35.07% 36.68% PAT 226.65 229.47 192.52 176.80 254.08 838.72 93.91 79.13 53.56 43.22 55.88 PAT before Minority Interest 226.65 229.47 192.52 176.80 254.08 838.72 93.91 79.13 53.56 43.22 55.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 18.32% 18.66% 17.28% 17.53% 18.74% 65.11% 13.45% 7.97% 5.70% 4.98% 7.00% PAT Growth -2.65% 19.19% 8.89% -30.42% -69.71% 793.11% 18.68% 47.74% 23.92% -22.66% EPS 136.54 138.23 115.98 106.51 153.06 505.25 56.57 47.67 32.27 26.04 33.66

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15 Dec 14 Dec 13
Shareholder's Funds 750.89 616.49 703.71 906.34 1,540.11 733.26 663.82 591.55 554.30 523.03 Share Capital 16.60 16.60 16.60 16.60 16.60 16.60 16.60 16.60 16.60 16.60 Total Reserves 726.45 592.61 683.24 887.80 1,523.51 716.66 647.22 574.95 537.70 506.43 Non-Current Liabilities 803.00 713.63 723.42 667.16 494.83 430.50 398.93 395.03 390.13 13.26 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 818.79 732.68 739.90 681.10 510.01 455.27 413.06 395.71 392.30 12.17 Current Liabilities 679.08 607.73 550.68 538.62 547.69 352.19 300.50 538.89 259.76 111.97 Trade Payables 237.04 172.08 178.91 123.96 91.42 83.28 75.10 65.55 43.77 36.46 Other Current Liabilities 42.48 42.32 36.64 94.51 78.02 82.21 68.23 61.03 59.62 43.49 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 399.56 393.33 335.13 320.15 378.25 186.70 157.17 412.31 156.37 32.02 Total Liabilities 2,232.97 1,937.85 1,977.81 2,112.12 2,582.63 1,515.95 1,363.25 1,525.47 1,204.19 648.26 Net Block 141.72 109.06 100.96 97.92 99.76 115.07 110.66 131.73 109.71 84.83 Gross Block 263.07 241.11 214.90 199.57 185.60 191.51 143.96 271.28 231.72 196.93 Accumulated Depreciation 121.35 131.32 113.94 101.65 61.39 51.22 24.82 139.55 122.01 112.10 Non Current Assets 1,061.69 953.98 938.96 847.28 693.45 636.69 613.07 579.47 581.00 170.54 Capital Work in Progress 32.49 40.60 39.15 21.45 17.35 8.90 29.98 7.00 27.63 9.23 Non Current Investment 0.00 0.00 0.00 3.30 3.82 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 885.23 801.72 795.90 724.61 572.52 511.59 470.50 435.76 434.13 58.39 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 1.13 1.93 4.98 9.53 18.09 Current Assets 1,171.28 983.87 1,038.85 1,264.84 1,889.18 879.26 750.18 946.00 623.19 477.72 Current Investments 0.00 0.00 0.00 0.00 0.00 69.97 27.78 42.28 23.87 24.29 Inventories 134.94 115.21 118.37 134.11 113.35 157.74 163.94 166.86 177.32 151.82 Sundry Debtors 115.71 83.44 59.81 95.27 66.17 122.66 107.04 126.57 104.53 84.12 Cash & Bank 440.22 324.53 468.91 639.09 1,243.42 278.18 279.27 188.42 163.95 187.69 Other Current Assets 480.41 7.95 6.36 7.76 466.24 250.71 172.15 421.87 153.52 29.80 Short Term Loans & Adv. 466.68 452.74 385.40 388.61 435.63 221.21 145.19 390.46 136.78 9.30 Net Current Assets 492.20 376.14 488.17 726.22 1,341.49 527.07 449.68 407.11 363.43 365.75 Total Assets 2,232.97 1,937.85 1,977.81 2,112.12 2,582.63 1,515.95 1,363.25 1,525.47 1,204.19 648.26

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15 Dec 14 Dec 13
Cash From Operating Activity 236.00 169.52 247.26 235.37 -130.39 53.66 107.04 83.47 4.95 0.45 PBT 314.20 253.37 233.28 354.85 1,137.57 152.19 115.18 83.33 66.56 88.25 Adjustment 41.49 27.31 40.89 -12.16 -913.68 7.66 14.87 16.32 21.10 2.97 Changes in Working Capital -30.03 -47.30 41.22 -5.73 -50.26 -46.66 30.11 15.64 -48.53 -50.94 Cash after chg. in Working capital 325.66 233.38 315.39 336.96 173.63 113.19 160.16 115.29 39.13 40.28 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -89.66 -63.86 -68.13 -101.59 -304.02 -59.53 -53.12 -31.82 -34.18 -39.83 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -21.50 -25.54 -32.27 164.64 1,269.72 -47.63 -74.97 -67.84 10.57 7.04 Net Fixed Assets -13.85 -27.66 -33.03 -18.07 -2.54 -26.47 104.34 -18.93 -53.19 -26.03 Net Investments 0.00 0.00 3.30 0.52 66.15 -42.19 14.50 -18.41 0.42 -0.65 Others -7.65 2.12 -2.54 182.19 1,206.11 21.03 -193.81 -30.50 63.34 33.72 Cash from Financing Activity -98.47 -288.63 -386.63 -883.41 -30.12 -21.98 -14.98 -11.92 -16.62 -4.82 Net Cash Inflow / Outflow 116.03 -144.65 -171.64 -483.40 1,109.21 -15.95 17.09 3.71 -1.10 2.67 Opening Cash & Equivalents 319.39 464.05 635.69 1,119.09 9.88 26.27 9.18 5.47 6.57 3.90 Closing Cash & Equivalent 435.42 319.40 464.05 635.69 1,119.09 10.32 26.27 9.18 5.47 6.57

Financial Ratios

Standalone

Right to Left

Description Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15 Dec 14 Dec 13
Book Value (Rs.) 447.62 366.99 421.59 544.82 927.78 441.72 399.89 356.36 333.92 315.08 ROA 11.00% 9.83% 8.65% 10.82% 40.93% 6.52% 5.48% 3.92% 4.67% 6.71% ROE 33.94% 29.41% 22.04% 20.79% 73.79% 13.44% 12.61% 9.35% 8.02% 11.10% ROCE 46.07% 38.45% 29.08% 29.01% 80.76% 21.79% 18.35% 14.54% 12.36% 17.53% Fixed Asset Turnover 5.27 5.17 4.87 7.04 6.83 4.24 4.96 3.87 4.19 4.40 Receivable days 27.36 22.20 28.06 21.73 26.75 58.92 41.40 43.30 38.34 32.82 Inventory Days 34.37 36.19 45.68 33.31 38.41 82.51 58.63 64.49 66.90 62.47 Payable days 206.35 188.51 177.09 43.33 49.94 53.71 33.69 25.86 20.54 20.95 Cash Conversion Cycle -144.61 -130.12 -103.36 11.71 15.22 87.72 66.33 81.93 84.70 74.34 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 409.05 604.26 292.60 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Top Investors:

nippon life india trustee ltd-a/c nippon india sma

life insurance corporation of india

icici prudential s&p bse 500 etf

uti - healthcare fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Procter&Gamble Healt - Quarterly Results
6th Feb 2024, 16:44 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback